A single dose of Immutep’s MS therapy, IMP761, was well tolerated and reduced T-cell activity for up to 23 days in healthy ...

Investigator-initiated trial aims to provide proof-of-concept for bexmarilimab in overcoming acquired resistance to checkpoint inhibitors, a major challenge for most melanoma and lung cancer patients ...

An MS degree provides focused, technical expertise that can accelerate your career in data-driven and analytical fields. MS programs offer flexible formats—especially for working professionals—while ...